Cargando…
Novel Biomarkers and Therapeutic Targets for Melanoma
Malignant melanoma is one of the most common cancers in the world. In the disease’s early stages, treatment involves surgery, in advanced stages however, treatment options were once scarce. There has been a paradigm shift in advanced melanoma treatment with the introduction of immunotherapy and targ...
Autores principales: | Sabag, Noa, Yakobson, Alexander, Retchkiman, Meir, Silberstein, Eldad |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9570448/ https://www.ncbi.nlm.nih.gov/pubmed/36232957 http://dx.doi.org/10.3390/ijms231911656 |
Ejemplares similares
-
Novel Biomarkers and Druggable Targets in Advanced Melanoma
por: Ferrucci, Pier Francesco, et al.
Publicado: (2021) -
COX-2 as a potential biomarker and therapeutic target in melanoma
por: Tudor, Diana Valentina, et al.
Publicado: (2020) -
Novel Therapeutic Targets in Melanoma
por: Cerezo, Michaël, et al.
Publicado: (2023) -
Increasing the Efficacy of SLNB in Cases of Malignant Melanoma Located in Close Proximity to the Lymphatic Basin
por: Bogdanov-Berezovsky, Alexander, et al.
Publicado: (2014) -
Oncogenic Tyrosine Phosphatases: Novel Therapeutic Targets for Melanoma Treatment
por: Pardella, Elisa, et al.
Publicado: (2020)